RDNTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
RadNet, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$69.27+0.47 (+0.68%)
Close on Oct 19, 2026
- Market cap
- $5.45B
- P/E (TTM)
- –
- Dividend yield
- –
RadNet, Inc. revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Imaging Center | $2.20B | $2.08B | $1.99B | $1.92B | $1.87B | $1.83B | $1.79B | $1.76B | $1.69B | $1.63B | $1.59B | $1.53B | 96.9% | +17.7% |
| Digital health | $114.29M | $102.59M | $92.69M | $83.61M | $75.16M | $70.27M | $65.71M | $61.57M | $57.38M | $53.16M | $49.58M | – | 5.0% | +52.1% |
| Anguilla | – | – | – | – | – | – | – | – | – | – | $12.47M | $8.74M | – | – |
| Operating income | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Imaging Center | $282.52M | $262.82M | $242.20M | $227.56M | $223.57M | $220.97M | $250.05M | – | – | – | – | – | +26.4% |
| Digital health | -$25.25M | -$23.31M | -$15.28M | -$13.15M | -$9.49M | -$5.92M | -$3.41M | – | – | – | – | – | +166.2% |
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Service fee revenue | $2.15B | $2.02B | $1.91B | $1.84B | $1.78B | $1.74B | $1.69B | $1.63B | $1.57B | $1.51B | $1.46B | $1.42B | 94.5% | +20.5% |
| Commercial insurance | $1.24B | $1.18B | $1.13B | $1.09B | $1.06B | $1.04B | $1.02B | $979.72M | $943.26M | $907.37M | $879.79M | $849.10M | 54.8% | +17.1% |
| Medicare | $540.60M | $506.11M | $476.99M | $459.86M | $439.45M | $424.84M | $410.07M | $391.88M | $379.01M | $365.08M | $356.51M | $340.94M | 23.8% | +23.0% |
| Other payors | $131.92M | $124.48M | $118.60M | $114.60M | $110.00M | $107.18M | $104.89M | – | – | – | – | – | 5.8% | +19.9% |
| Revenue under capitation arrangements | $123.86M | $123.90M | $125.54M | $125.19M | $127.31M | $134.11M | $136.58M | $140.50M | $146.98M | $149.81M | $153.43M | $155.66M | 5.5% | -2.7% |
| Other revenue | $93.47M | $77.28M | $65.02M | $55.84M | $53.88M | $50.21M | $46.72M | $53.85M | $41.00M | $36.34M | $32.58M | $29.42M | 4.1% | +73.5% |
| Medicaid | $55.91M | $54.06M | $51.74M | $49.69M | $47.11M | $45.52M | $44.74M | $44.81M | $44.43M | $43.23M | $42.30M | $39.35M | 2.5% | +18.7% |
| Workers' compensation/personal injury | $49.42M | $46.53M | $44.70M | $43.03M | $41.91M | $42.27M | $43.67M | $44.65M | $44.16M | $45.74M | $46.41M | $46.31M | 2.2% | +17.9% |
| Management fee revenue | $29.89M | $28.72M | $27.52M | $26.43M | $25.63M | $25.05M | $24.68M | $23.99M | $21.67M | $19.60M | $17.94M | $17.24M | 1.3% | +16.6% |
| Anguilla | – | – | – | – | – | – | – | – | – | – | $12.47M | $8.74M | – | – |
| Other patient revenue | – | – | – | – | – | – | – | $46.57M | $46.40M | $44.17M | $42.25M | $39.71M | – | – |
| Imaging Center Segment Revenue | – | – | – | – | – | – | – | $1.75B | $1.69B | $1.64B | $1.60B | $1.54B | – | – |
By region
From the segment and revenue-disaggregation notes of RadNet's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.